References
- Shoop WL , MrozikH, FisherMH. Structure and activity of avermectins and milbemycins in animal health. Vet. Parasitol.59 (2), 139–156 (1995).
- Moreno L , DominguezP, FariasCet al. Ivermectin pharmacokinetics, metabolism and tissue/egg residue profiles in laying hens. J. Agric. Food. Chem.63 (47), 10327–10332 (2015).
- Laffont CM , ToutainP-L, AlvinerieM, Bousquet-MélouA. Intestinal secretion is a major route for parent ivermectin elimination in the rat. Drug Metab. Dispos.30 (6), 626–630 (2002).
- Chaccour C , HammannF, RabinovichNR. Ivermectin to reduce malaria transmission I. pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar. J.16 (1), 161 (2017).
- Stromectol, TGA-Australia approved package insert. Merck & Co., NJ, USA.
- Kose LP , Gülçinİ, ÖzdemirH, AtaseverA, AlwaselSH, SupuranCT. The effects of some avermectins on bovine carbonic anhydrase enzyme. J. Enzyme Inhib. Med. Chem.31 (5), 773–778 (2016).
- Cuneyt C , İlhamiG. The toxicological effects of some avermectins on goat liver carbonic anhydrase enzyme. J. Biochem. Mol. Toxicol.32 (1), e22010 (2018).
- Köksal Z , KalınR, Gülçinİ, ÖzdemirH, AtaseverA. Impact of some avermectins on lactoperoxidase in bovine milk. Int. J. Food Prop.19 (6), 1207–1216 (2016).
- Taylor MJ , HoeraufA, BockarieM. Lymphatic filariasis and onchocerciasis. Lancet376 (9747), 1175–1185 (2010).
- Lifschitz A , VirkelG, PisAet al. Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle. Vet. Parasitol.86 (3), 203–215 (1999).
- Mckellar QA , BenchaouiHA. Avermectins and milbemycins. J. Vet. Pharmacol. Ther.19 (5), 331–351 (1996).
- Turner SA , MacLeanJD, FleckensteinL, GreenawayC. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am. J. Trop. Med. Hyg.73 (5), 911–914 (2005).
- Thomsen EK , SanukuN, BaeaMet al. Efficacy, safety and pharmacokinetics of coadministered diethylcarbamazine, albendazole and Ivermectin for treatment of bancroftian filariasis. Clin. Infect. Dis.62 (3), 334–341 (2016).
- Leung V , Al-RawahiGN, GrantJ, FleckensteinL, BowieW. Failure of subcutaneous ivermectin in treating strongyloides hyperinfection. Am J. Trop. Med. Hyg.79 (6), 853–855 (2008).
- Pérez R , GodoyC, PalmaCet al. Plasma profiles of ivermectin in horses following oral or intramuscular administration. J. Vet. Med. A50 (6), 297–302 (2003).
- Chiodini PL , ReidAJC, WiselkaMJ, FirminR, FowerakerJ. Parenteral ivermectin in strongyloides hyperinfection. Lancet355 (9197), 43–44 (2000).
- Marty FM , LowryCM, RodriguezMet al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin. Infect. Dis.41 (1), e5–e8 (2005).
- Zeng Z , AndrewNW, ArisonBH, Luffer-AtlasD, WangRW. Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes. Xenobiotica28 (3), 313–321 (1998).
- Lespine A , MénezC, BourguinatC, PrichardRK. P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing transport-dependent anthelmintic resistance. Int. J. Parasitol. Drugs Drug Resist.2, 58–75 (2012).
- Gokbulut C , BilgiliA, HanedanB, AksitD, AksoyAM, TurgutC. Breed-related plasma disposition of ivermectin following subcutaneous administration in kilis and damascus goats. Res. Vet. Sci.87 (3), 445–448 (2009).
- Ricart Arbona RJ , LipmanNS, RiedelER, WolfFR. Treatment and eradication of murine fur mites: I. toxicologic evaluation of ivermectin-compounded feed. J. Am. Assoc. Lab. Anim. Sci.49 (5), 564–570 (2010).
- Bennett DC , ChengKM. Ivermectin residues in squab. Poult. Sci.91 (11), 2808–2811 (2012).
- Kitzman D , WeiS-Y, FleckensteinL. Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies. J. Pharm. Biomed. Anal.40 (4), 1013–1020 (2006).
- Macedo F , MarsicoET, Conte-JúniorCA, De ResendeMF, BrasilTF, Pereira NettoAD. Development and validation of a method for the determination of low-ppb levels of macrocyclic lactones in butter, using HPLC-fluorescence. Food Chem.179 (Supplement C), 239–245 (2015).
- Åsbakk K , BendiksenHR, OksanenA. Ivermectin in reindeer feces: determination by HPLC. J. Agric. Food. Chem.47 (3), 999–1003 (1999).
- Payne LD , HicksMB, WehnerTA. Determination of abamectin and/or ivermectin in cattle feces at low parts per billion levels using HPLC with fluorescence detection. J. Agric. Food. Chem.43 (5), 1233–1237 (1995).
- Sanbonsuge A , TakaseT, ShihoD-I, TakagaiY. Gas chromatography-mass spectrometric determination of ivermectin following trimethylsilylation with application to residue analysis in biological meat tissue samples. Anal. Methods3 (9), 2160–2164 (2011).
- Rübensam G , BarretoF, HoffRB, PizzolatoTM. Determination of avermectin and milbemycin residues in bovine muscle by liquid chromatography-tandem mass spectrometry and fluorescence detection using solvent extraction and low temperature cleanup. Food Control29 (1), 55–60 (2013).
- Croubels S , De BaereS, CherletM, De BackerP. Determination of ivermectin B1a in animal plasma by liquid chromatography combined with electrospray ionization mass spectrometry. J. Mass Spectrom.37 (8), 840–847 (2002).
- Dahiya M , DubeyN, SinghP, SinghGN. Development and validation of LC–MS/MS method to determine the residue of veterinary drugs ivermectin, doramectin and moxidectin in milk. Indian J. Chem.52, 1313–1317 (2013).
- Huang J-X , LuD-H, WanK, WangF-H. Low temperature purification method for the determination of abamectin and ivermectin in edible oils by liquid chromatography–tandem mass spectrometry. Chin. Chem. Lett.25 (4), 635–639 (2014).
- Krogh KA , BjörklundE, LoefflerD, FinkG, Halling-S⊘rensenB, TernesTA. Development of an analytical method to determine avermectins in water, sediments and soils using liquid chromatography–tandem mass spectrometry. J. Chromatogr. A1211 (1), 60–69 (2008).
- Ortiz AJ , CortezV, AzzouzA, VerdúJR. Isolation and determination of ivermectin in postmortem and in vivo tissues of dung beetles using a continuous solidphase extraction method followed by LC-ESI+-MS/MS. PLoS ONE12 (2), e0172202 (2017).
- Howells L , SauerMJ. Multiresidue analysis of avermectins and moxidectin by ion-trap LC-MS. Analyst126 (2), 155–160 (2001).
- Lehner AF , PetzingerE, StewartJet al. ESI+ MS/MS confirmation of canine ivermectin toxicity. J. Mass Spectrom.44 (1), 111–119 (2009).
- Hu Y , LiX, ZhangLet al. Mesoporous alumina as a solid-phase extraction adsorbent for the determination of abamectin and ivermectin in vegetables by liquid chromatography-tandem mass spectrometry. Anal. Methods6 (13), 4734–4741 (2014).
- Cheng C , LiuL-C. On-line solid-phase extraction coupled liquid chromatography-ESI-ion trap-mass spectrometry for analysis of abamectin and ivermectin residues in milk. Anal. Methods6 (5), 1581–1589 (2014).
- US FDA . Guidance for industry – bioanalytical method validation. Center for Drug Evaluation and Research, US Department of Health and Human Services, MD, USA (2013). http://academy.gmp-compliance.org/guidemgr/files/UCM368107.PDF.
- US FDA . Guidance for industry-bioanalytical method validation. Center for Drug Evaluation and Research, US Department for Health and Human Services, Center for Veterinary Medicine, MD, USA (2018). https://www.fda.gov/downloads/drugs/guidances/ucm070107.Pdf.
- Chhonker YS , EdiC, MurryDJ. LC–MS/MS method for simultaneous determination of diethylcarbamazine, albendazole and albendazole metabolites in human plasma: application to a clinical pharmacokinetic study. J. Pharm. Biomed. Anal.151, 84–90 (2018).
- Bland JM , AltmanDG. Measuring agreement in method comparison studies. Stat. Methods Med. Res.8 (2), 135–160 (1999).
- Fluhler E , VazvaeiF, SinghalPet al. Repeat analysis and incurred sample reanalysis: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team. AAPS J.16 (6), 1167–1174 (2014).